TELA Bio, Inc.
TELA
$0.57
-$0.05-8.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.84% | 12.24% | 16.34% | 12.78% | 18.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.84% | 12.24% | 16.34% | 12.78% | 18.56% |
| Cost of Revenue | 13.92% | 16.33% | 21.59% | 20.59% | 24.89% |
| Gross Profit | 16.76% | 10.40% | 14.00% | 9.36% | 15.75% |
| SG&A Expenses | -0.62% | -5.89% | -2.42% | -0.45% | 6.44% |
| Depreciation & Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73% | -1.53% | 1.27% | 2.40% | 8.26% |
| Operating Income | 19.04% | 22.27% | 19.73% | 12.09% | 5.40% |
| Income Before Tax | -1.62% | 5.94% | 3.04% | -8.04% | 18.60% |
| Income Tax Expenses | 259.72% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.62% | 6.08% | 3.18% | -7.81% | 18.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.62% | 6.08% | 3.18% | -7.81% | 18.91% |
| EBIT | 19.04% | 22.27% | 19.73% | 12.09% | 5.40% |
| EBITDA | 19.51% | 23.04% | 20.55% | 12.80% | 5.97% |
| EPS Basic | 40.20% | 47.45% | 34.86% | 15.52% | 32.64% |
| Normalized Basic EPS | 52.43% | 55.48% | 44.70% | 28.59% | 17.54% |
| EPS Diluted | 40.20% | 47.45% | 34.86% | 15.52% | 32.75% |
| Normalized Diluted EPS | 52.43% | 55.48% | 44.70% | 28.59% | 17.54% |
| Average Basic Shares Outstanding | 64.65% | 78.93% | 58.23% | 39.17% | 24.75% |
| Average Diluted Shares Outstanding | 64.65% | 78.93% | 58.23% | 39.17% | 24.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |